Lawmakers slam slow progress on UK drug pricing overhaul

LONDON Wed Jan 16, 2013 1:09pm IST

Related Topics

LONDON (Reuters) - British lawmakers have criticized the government's failure to detail a new system for medicines pricing that is due to be introduced next January, saying lack of clarity is creating uncertainty for industry and doctors.

The House of Commons Health Committee called on the government on Wednesday to make clear its plans by the end of March 2013.

"There has been extensive discussion of the principle of value-based pricing but it remains a source of concern that so little progress has been made on defining this nebulous concept," the committee said in a report.

The government announced in 2010 that it planned an overhaul medicine pricing from 2014 by adopting a new system of "value-based pricing" - a concept that has so far not been clearly defined.

Drug prices are under growing pressure across Europe as governments tackle ballooning budget deficits, and firms fear the British changes might lead to direct price controls or further obstacles to launching new therapies.

"We do not regard it as acceptable that the arrangements for value-based pricing have still not been settled and that those who will have to work with those arrangements are still unclear about what value-based pricing will mean in practice," the committee said.

"Industry needs certainty about how it should bring its products to the NHS (National Health Service), and patient groups and clinicians need to understand what their role will be and how they can make their views heard."

(Reporting by Ben Hirschler; Editing by Hans-Juergen Peters)

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

  • Most Popular
  • Most Shared

REUTERS EXCLUSIVE

HEALTH SHOWCASE

Marital Connection

Marital Connection

Spouse personality may affect career success  Full Article 

Influenza Vaccines

Influenza Vaccines

Plant-based vaccines challenge big pharma for $3 billion flu market  Full Article 

Ebola Outbreak

Ebola Outbreak

Traveler from Liberia is first Ebola patient diagnosed in U.S.  Full Article 

Birth Control

Birth Control

Long-acting reversible contraceptives best for teens: pediatricians.  Full Article 

Childhood Obesity

Childhood Obesity

Antibiotics in infancy may be linked to childhood obesity: study.  Full Article 

MERS Update

MERS Update

Austria reports first MERS case in Saudi national: media.  Full Article 

Sinusitis Drug

Sinusitis Drug

Sanofi-Regeneron drug has positive trial results in chronic sinusitis.  Full Article